Interestingly, the LNMAT2-mediated mechanism of PROX1 activation is VEGF-C-independent, explaining why approximately 20% of bladder cancers with LN metastasis have low VEGF-C expression [181, 182]. This evidence concerns the gene PROX1 and urinary bladder carcinoma.